Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
65 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Strides Shasun Limited (Strides Shasun), formerly Strides Arcolab Limited, which offers generic products. It focuses on the development and manufacture of intellectual property -led pharmaceutical products. Strides Shasun manufactures drugs in various oral dosage forms such as general tablets, hard gelatin capsules and soft gelatin capsules and potent drugs. The company provides services in various areas which include pharma generics, bio generics and branded generics. Strides Shasuns products find applications in the treatment of diseases such as AIDS, malaria and tuberculosis. It also works in partnership with other organizations to develop novel drugs.

Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  
Source:
Document ID
GDPH33228D
Country
Industry
Ticker
STAR=IN
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables42
  List of Figures61
Strides Shasun Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201662
Strides Shasun Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201681
Strides Shasun Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201691
Strides Shasun Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016102
Strides Shasun Limited, Medical Devices Deals, 2010 to YTD 2016121
Strides Shasun Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016133
Strides Shasun Limited, Pharmaceuticals &Healthcare, Deal Details1645
  Asset Purchase161
    Strides Shasun Acquires Jointflex, Fergon and Vanquish Brands from Moberg Pharma for USD10 Million161
    Strides Arcolab to Acquire Seven Brands from Johnson &Johnson171
    Strides Arcolab to Acquire Ranbaxy's CNS Business from Sun Pharma for USD25 Million181
    Strides Arcolab Acquires Generic Pharma Business and Related Assets from Aspen Pharmacare for USD210 Million192
    Strides Arcolab Acquires Prescription Products from Aspen Global for USD92 million211
    Strides Arcolab to Acquire 74% Stake in Branded Generics Unit of Bafna Pharma for USD8 Million221
    Strides Arcolab Acquires Sterile Drugs Manufacturing Facility From Star Drugs and Research Labs For US$23.5 Million231
    Strides Acquires Brazilian Manufacturing Facility From Aspen Pharmacare241
  Private Equity251
    Apax Partners Acquires 1.2% stake in Strides Arcolab for USD8 Million251
  Partnerships261
    Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab261
    Strides Arcolab Forms Joint Venture With Bio-XCell271
    Strides Arcolab Enters Into Joint Venture Agreement With BioChimico281
    Pfizer Enters Into Co-Marketing Agreement With Strides Arcolab291
  Merger301
    Strides Arcolab to Merge with Shasun Pharma301
  Licensing Agreements311
    Gilead Sciences Enters into Licensing Agreement with Strides Arcolab311
    Gilead Sciences Enters into Licensing Agreement with Strides Arcolab322
    Pfenex Enters into Licensing Agreement with Strides Arcolab341
    Strides Arcolab Enters Into Licensing Agreement With Eli Lilly For Generic Cancer Medicines351
    Strides Arcolab Enters Into Licensing Agreement With Gilead Sciences For Generic Versions Of Emtricitabine362
    Gilead Sciences Extends Licensing Agreement With Strides Arcolab For Tenofovir, Elvitegravir, Cobicistat And Quad382
    Strides Arcolab Enters Into Licensing Agreement With Pfizer401
  Equity Offering411
    Strides Arcolab Invests in Oncobiologics411
    Strides Arcolab Completes Private Placement Of US$100 Million422
  Asset Transactions441
    Zydus Cadila Healthcare To Acquire Domestic Generic Business From Strides Arcolab441
  Acquisition451
    Strides Shasun Acquires 51% Stake in Generic Partners451
    Strides Shasun Acquires 51% Stake in Universal Corporation for USD14 Million461
    Strides Shasun to Sell Shasun Pharma Solutions471
    Strides Arcolab to Acquire Majority Stake in Medispan481
    GMS to Acquire 25.1% Stake in Stelis Biopharma from Strides Arcolab for USD22 Million491
    Mylan Completes Acquisition Of Agila Specialties From Strides Arcolab For Up To US$1.75 Billion503
    PROPARCO Acquires 20% Stake In Strides Africa From Strides Arcolab For US$13 Million531
    Watson Pharma Acquires Ascent Pharmahealth From Strides Arcolab And Dennis Bastas For US$394 Million542
    Strides Arcolab Completes Acquisition Of Additional 33.7% Stake In Ascent Pharmahealth For US$33 Million562
    Strides Arcolab Acquires 70% Stake In Inbiopro Solutions582
    Strides Acquires 50% Stake In Onco Therapies And Onco Labs From Aspen601
Strides Shasun Limited - Key Competitors611
Key Employees621
Locations And Subsidiaries632
  Head Office631
  Other Locations &Subsidiaries632
Appendix651
  Methodology651
  About GlobalData651
  Contact Us651
  Disclaimer651

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Strides-Shasun-Limited-STAR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7799>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Strides Shasun Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Strides-Shasun-Limited-STAR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7799>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research